2025 HCPCS Code Q0240
Injection, casirivimab and imdevimab, 600 mg
TAGS: casirivimab| Notice | HCPCS Q0240 terminated on December 12, 2024. |
| Short Description | Casirivi and imdevi 600 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | July 30, 2021 |
| HCPCS Action Effective Date | December 13, 2024 |
| HCPCS Pricing Indicator Code | 54 - Vaccinations |
| HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q5123 - Inj. riabni, 10 mg
- Q5124 - Inj. byooviz, 0.1 mg
- Q5125 - Inj, releuko 1 mcg
- Q5126 - Inj alymsys 10 mg
- Q5127 - Inj, stimufend, 0.5 mg
- Q5128 - Inj, cimerli, 0.1 mg
- Q5129 - Inj, vegzelma, 10 mg
- Q5130 - Inj, fylnetra, 0.5 mg
- Q5131 - Inj, idacio, 20 mg
- Q5132 - Inj, abrilada, 10 mg
- Q5133 - Inj, tofidence, 1 mg
- Q5134 - Inj, tyruko, 1 mg
- Q5135 - Inj, tyenne, 1 mg
- Q5136 - Inj. denosumab-bbdz, 1 mg
- Q5137 - Inj, wezlana, sub cu, 1 mg
- Q5138 - Inj, wezlana, iv, 1 mg
- Q5139 - Inj, eculizumab-aeeb, 10 mg
- Q5140 - Inj adalimumab-fkjp, 1 mg
- Q5141 - Inj adalimumab-aaty, 1 mg
- Q5142 - Inj adalimumab-ryvk, 1 mg